Delivery Order SPE2DB25D3022-SPE2DB25FWCRV
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,208.72 for NEXLETOL 180 mg tablets (30-count units) with an ultimate completion date of July 11, 2025. This is a firm fixed-price, non-set-aside contract performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Nexletol 180 mg tablets in quantities of 30 units. This competitive, firm fixed-price delivery order carries a ceiling value of $1,269.01 and has an ultimate completion date of August 19, 2025. The contract involves no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,988.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Nexletol 180 mg tablets in quantities of 30 units. This is a non-set-aside delivery order with an ultimate completion date of September 11, 2025, and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,068.11 by the Defense Logistics Agency (DLA) on July 11, 2025, for the supply of Nexletol 180 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 14, 2025, and represents a child award under AmerisourceBergen's larger indefinite delivery contract with DLA. The pharmaceutical distributor will fulfill...
- The Defense Logistics Agency awarded a delivery order valued at $1,162.98 to AmerisourceBergen Drug Corp for NEXLETOL 180 mg tablets (30-count units) on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. NEXLETOL is a non-statin, non-ezetimibe medication used to manage cholesterol levels in patients with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Nexletol 180 mg tablets (30-count units) with a contract ceiling value of $1,216.14. This firm fixed-price delivery order, which carries an ultimate completion date of June 6, 2025, represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,250.17 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Nexletol 180 mg on August 8, 2025, with completion targeted for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Nexletol 180 mg tablets (30-unit packaging) valued at $1,389.23. This competitively awarded, firm fixed-price delivery order is non-set-aside and has a completion date of July 31, 2025. The award is issued to AmerisourceBergen Drug Corp's Corporate Office, with performance taking place at the company's Conshohocken, Pennsylvania headquarters, which serves as a major hub for...
- This is a $3,793.11 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXLETOL 180 MG TABLET, a medication, with a completion date of May 27, 2025. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nexletol 180 mg tablets. The $1,434.84 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that provides pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has an ultimate completion date of August 5, 2024. No...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWCRVDelivery Order
The Defense Logistics Agency awarded a $2,172.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nexletol 180 mg tablets (30-count units) with an ultimate completion date of September 24, 2025. This non-set-aside award was issued on September 23, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026 that supports global pharmaceutical supply for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical vendor through competitive procurement. As a primary supplier within the DLA Medical Supply Chain, the company maintains a comprehensive portfolio of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Nexletol, a cholesterol-management medication, exemplifies the company's role in supporting Department of Defense healthcare operations and military beneficiary needs through the established prime vendor vehicle structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/23/25 |